{"transactions":[{"id":1013874,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T16:30:08.000Z","date":"2025-10-23","kind":"sale","planned":false,"acquired":false,"shares":30,"price":2.29,"value":68.7,"ownership":{"direct":true},"balance_after":25,"source":{"system":"sec-edgar","filing":"0001214659-25-015288","document":"marketforms-71141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465925015288/marketforms-71141.xml","form_type":"4"}},{"id":1514461,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T16:30:15.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":666,"price":0.881,"value":586.746,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares were sold in an individual retirement account owned by Mrs. McGrath's spouse."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-24-009438","document":"marketforms-65906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465924009438/marketforms-65906.xml","form_type":"5"}},{"id":1940354,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-23T16:30:12.000Z","date":"2023-03-22","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.435,"value":4350.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares were purchased in an individual retirement account owned by Mrs. McGrath's spouse.  Mrs. McGrath disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001214659-23-004146","document":"marketforms-61011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465923004146/marketforms-61011.xml","form_type":"4"}},{"id":2300504,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T17:00:23.000Z","date":"2022-03-28","kind":"sale","acquired":false,"shares":25000,"price":1.213,"value":30325.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The original Form 4 filed on April 6, 2022, is amended by this Form 4 amendment to correct a typographical error in Table I Column 4 from \"A\" to \"D\"."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001214659-22-004992","document":"marketforms-55978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465922004992/marketforms-55978.xml","form_type":"4/A","original_submission_date":"2022-04-06"}},{"id":2302704,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T19:47:06.000Z","date":"2022-03-28","kind":"sale","acquired":true,"shares":25000,"price":1.213,"value":30325.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001214659-22-004914","document":"marketforms-55974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465922004914/marketforms-55974.xml","form_type":"4"}},{"id":2333580,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2022-03-15T19:09:18.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022."}],"balance_after":0,"derivative":{"expiration_date":"2022-03-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-22-003986","document":"marketforms-55802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465922003986/marketforms-55802.xml","form_type":"4"}},{"id":2333579,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-15T19:09:18.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the vesting of restricted stock."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001214659-22-003986","document":"marketforms-55802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465922003986/marketforms-55802.xml","form_type":"4"}},{"id":2540741,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-10-18T17:00:57.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":47222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022.  2,778 shares previously vested on September 13, 2021."}],"balance_after":50000,"derivative":{"expiration_date":"2022-03-15","underlying":"Common Stock","underlying_shares":47222},"source":{"system":"sec-edgar","filing":"0001214659-21-010561","document":"marketforms-54024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465921010561/marketforms-54024.xml","form_type":"4"}},{"id":2540740,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-18T17:00:57.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":47222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the vesting of restricted stock."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001214659-21-010561","document":"marketforms-54024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465921010561/marketforms-54024.xml","form_type":"4"}},{"id":2569684,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-09-15T17:01:03.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock grant vests in 36 equal monthly installments commencing on September 13, 2021."}],"balance_after":97222,"derivative":{"expiration_date":"2024-09-13","underlying":"Common Stock","underlying_shares":2778},"source":{"system":"sec-edgar","filing":"0001214659-21-009540","document":"marketforms-53816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465921009540/marketforms-53816.xml","form_type":"4"}},{"id":2569683,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T17:01:03.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the vesting of restricted stock."}],"balance_after":2778,"source":{"system":"sec-edgar","filing":"0001214659-21-009540","document":"marketforms-53816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465921009540/marketforms-53816.xml","form_type":"4"}},{"id":2632248,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-16T17:01:05.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options (the \"Options\") vest in 36 equal monthly installments commencing on September 13, 2021 and are exercisable upon vesting."}],"balance_after":300000,"derivative":{"exercise_price":2.5,"expiration_date":"2026-09-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001214659-21-007597","document":"marketforms-53420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465921007597/marketforms-53420.xml","form_type":"4"}},{"id":2632247,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":73976,"kind":"person","name":"McGrath Lynne Fahey","position":1,"cik":"0001866270","reported_name":"McGrath Lynne Fahey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-07-16T17:01:05.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock grant vest contemporaneously with the Options (as defined below)."}],"balance_after":100000,"derivative":{"expiration_date":"2024-09-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-21-007597","document":"marketforms-53420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866270/000121465921007597/marketforms-53420.xml","form_type":"4"}}]}